Teva Pharmaceutical Industries Limited (TEVA) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Teva Pharmaceutical Indus...

NYSE: TEVA · Real-Time Price · USD
18.95
0.47 (2.54%)
At close: Sep 05, 2025, 3:59 PM
18.95
0.00%
After-hours: Sep 05, 2025, 07:47 PM EDT

Teva Pharmaceutical Industries Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
16.54B 15.85B 14.93B 15.88B
Cost of Revenue
8.48B 8.2B 7.95B 8.28B
Gross Profit
8.06B 7.65B 6.97B 7.59B
Operating Income
-303M 433M 2.68B 1.72B
Interest Income
n/a 68M 920M 891M
Pretax Income
-1.28B -624M -3.14B 667M
Net Income
-1.64B -559M -2.45B 417M
Selling & General & Admin
3.7B 3.5B 3.44B 3.53B
Research & Development
998M 953M 838M 967M
Other Expenses
3.67B 2.76B 4.89B 1.38B
Operating Expenses
8.37B 7.21B 9.17B 5.88B
Interest Expense
1B 1.03B 981M 1.06B
Selling & Marketing Expenses
2.54B 2.34B 2.27B 2.43B
Cost & Expenses
16.85B 15.41B 17.12B 14.16B
Income Tax Expense
676M -7M -643M 211M
Shares Outstanding (Basic)
1.13B 1.12B 1.11B 1.1B
Shares Outstanding (Diluted)
1.13B 1.12B 1.11B 1.11B
EPS (Basic)
-1.45 -0.5 -2.2 0.38
EPS (Diluted)
-1.45 -0.5 -2.2 0.38
EBITDA
777M 1.57B -874M 2.99B
EBIT
-282M 417M -2.18B 1.66B
Depreciation & Amortization
1.06B 1.15B 1.31B 1.33B